SANGAMO THERAPEUTICS, INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sangamo Therapeutics, Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Sangamo Therapeutics, Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $18.7M, a 60.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $18.7M -$28.1M -60.1% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $20.9M -$27.8M -57% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $26M -$36M -58.1% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $27.2M -$37.7M -58.1% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $46.8M -$21.9M -31.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $48.7M -$22.2M -31.3% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $62M -$11.2M -15.3% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $65M -$1.27M -1.92% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $68.7M +$393K +0.58% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $70.9M +$575K +0.82% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $73.2M +$2.14M +3.01% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $66.2M -$5.41M -7.55% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $68.3M -$5.2M -7.07% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $70.3M -$5.05M -6.7% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $71M -$6.24M -8.08% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $71.6M -$5.87M -7.57% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $73.5M -$5.93M -7.47% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $75.4M +$47.2M +167% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $77.3M +$77.3M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $77.5M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $79.4M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $28.2M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.